1. What were the top biotech IPOs in 2019? — Coronovirus could threaten US drug supplies — Novartis gets a boost in blockbuster MS race — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Great things ahead for Atherotech

Discussion in 'Atherotech' started by Anonymous, Jun 26, 2015 at 10:06 AM.

  1. anonymous

    anonymous Guest

    Atherotech increased sales positions while they should have focused on relationships with payers for understanding the VAP. Instead our moron leaders and board sat around picking their nose.
    quality vs quality idiots
     
  2. anonymous

    anonymous Guest

    Bringing on the deadbeats from Thermo Fischer was a very bad decision.
     
  3. anonymous

    anonymous Guest

    Actually that was a good move great people sorry you cant move on, good thing you were fired.
     
  4. anonymous

    anonymous Guest

    they will continue to erode and no way to reverse course
     
  5. anonymous

    anonymous Guest

    what's wrong with fisher? deadbeats?